These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 63766)

  • 21. [Results of long-term treatment of hyperlipemias].
    Reuter W
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:156-9. PubMed ID: 4200339
    [No Abstract]   [Full Text] [Related]  

  • 22. [From the Adverse Drug Reaction Committee: clofibrate and biliary tract calculi].
    Laake K; Borchgrevink C
    Tidsskr Nor Laegeforen; 1976 Jan; 96(1):46. PubMed ID: 1257957
    [No Abstract]   [Full Text] [Related]  

  • 23. Clofibrate-induced myopathy in a patient with primary hypothyroidism.
    Hattori N; Shimatsu A; Murabe H; Nishimura M; Nakamura H; Imura H
    Jpn J Med; 1990; 29(5):545-7. PubMed ID: 2089182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
    Watermeyer GS; Mann JI; Truswell AS; Levy I
    S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Letter: Acute-on-chronic renal failure precipitated by clofibrate.
    Dosa S; Mallick NP; Slotki IN
    Lancet; 1976 Jan; 1(7953):250. PubMed ID: 55557
    [No Abstract]   [Full Text] [Related]  

  • 26. [Bezafibrate is not the same as clofibrate].
    Fortschr Med; 1979 Jan; 97(2):VI-VII. PubMed ID: 759280
    [No Abstract]   [Full Text] [Related]  

  • 27. Control of clofibrate toxicity in uremic hypertriglyceridemia.
    Goldberg AP; Sherrard DJ; Haas LB; Brunzell JD
    Clin Pharmacol Ther; 1977 Mar; 21(3):317-25. PubMed ID: 837651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potency disorders during the therapy or metabolic diseases].
    Overzier C
    Med Welt; 1977 Apr; 28(15):754. PubMed ID: 859432
    [No Abstract]   [Full Text] [Related]  

  • 29. [Etofibrate and clofibrate in a double-blind trial on patients with raised serum-lipid levels (author's transl)].
    Kaffarnik H; Schneider J; Haase W
    Dtsch Med Wochenschr; 1975 Nov; 100(48):2486-8. PubMed ID: 1104303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drugs which decrease serum lipids].
    Oye I
    Tidsskr Nor Laegeforen; 1973 Jan; 93(1):32-3. PubMed ID: 4691222
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use of symfibrate in the treatment of hyperlipemias. Preliminary data].
    Giuliani A; Trezzini C; Urbinati G; Conti R
    Clin Ter; 1979 Mar; 88(5):481-9. PubMed ID: 466970
    [No Abstract]   [Full Text] [Related]  

  • 32. Clofibrate effect on alkaline phosphatase in renal failure.
    Kijima Y; Sasaoka T; Kanayama M; Kubota S
    N Engl J Med; 1977 Jul; 297(2):113. PubMed ID: 865570
    [No Abstract]   [Full Text] [Related]  

  • 33. Clofibrate.
    Br Med J; 1970 Sep; 3(5723):632. PubMed ID: 5470094
    [No Abstract]   [Full Text] [Related]  

  • 34. High death rate from neoplasms in French diabetic and non-diabetic men.
    Balkau B; Charles MA; Eschwège E
    Lancet; 1998 May; 351(9114):1512. PubMed ID: 9605828
    [No Abstract]   [Full Text] [Related]  

  • 35. [Problems of long-term treatment of hyperlipoproteinemia with clofibrinic acid].
    Hanefeld M; Schulze J; Fritz T; Kemmer C
    Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:160 c. PubMed ID: 4200340
    [No Abstract]   [Full Text] [Related]  

  • 36. [Correction of hyperdyslipidemia using polyene-structure substances. Controlled clinical trial].
    Pagliano FM
    Arch Sci Med (Torino); 1979; 136(2):303-8. PubMed ID: 391176
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipid-lowering drugs.
    Med Lett Drugs Ther; 1975 Jun; 17(12):49-50. PubMed ID: 1128443
    [No Abstract]   [Full Text] [Related]  

  • 38. Clofibrate-induced muscle damage in patients with chronic renal failure.
    Pierides AM; Alvarez-Ude F; Kerr DN
    Lancet; 1975 Dec; 2(7948):1279-82. PubMed ID: 54800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Long-term management of various hyperlipidemias using clofibrate].
    Studlar M; Pichler O; Kindler K
    Wien Med Wochenschr; 1975 Dec; 125(50-52):746-51. PubMed ID: 1229130
    [No Abstract]   [Full Text] [Related]  

  • 40. [Demonstration of the role of cholelithiasis in the onset of acute pancreatitis occurring during clofibrate (or its analog) treatment of atherogenic hyperlipemia].
    De Gennes JL; Dairou F; Surbled-Delas B
    Ann Med Interne (Paris); 1978; 129(6-7):435-9. PubMed ID: 686580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.